PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1100 participants.

Also called NCT03559114

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03559114
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03559114. Randomized; triple masking; primary purpose prevention. Start 2018-07-19 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Acronym
PROTEST
Condition
Traumatic Brain Injury
Intervention (Drug)
Dalteparin
Intervention (Drug)
Saline
Lead sponsor
Sunnybrook Health Sciences Centre (class: other)
Collaborator
Sunnybrook Research Institute (class: other)

Record details

Record id
cardio:ct-nct03559114
Content hash
b52ba0e0a6bac61efb32bfaa05c929d7febf450a9ae10575f4b0f8f3b8027fc3